Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Navidea Biopharmaceuticals Inc NAVB

Healthcare Biotechnology
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of undetected disease. The Company’s business is focused on... see more

Recent & Breaking News (GREY:NAVB)

Navidea Biopharmaceuticals to Host Third Quarter 2019 Earnings Conference Call and Corporate Update

Business Wire October 31, 2019

Navidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis

Business Wire October 29, 2019

Navidea Biopharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Business Wire September 6, 2019

Navidea Biopharmaceuticals Announces Receipt of Notice of Award

Business Wire August 27, 2019

Navidea Biopharmaceuticals Reports Second Quarter 2019 Financial Results

Business Wire August 8, 2019

Navidea Biopharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update

Business Wire August 1, 2019

Navidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study Results

Business Wire June 24, 2019

Navidea Biopharmaceuticals Announces Closing of Public Offering of Common Stock

Business Wire June 18, 2019

Navidea Biopharmaceuticals Announces Day and Time of SNMMI Presentation of Phase 1/2 Study Results and Enrollment Update on its Phase 2B Study

Business Wire June 17, 2019

Navidea Biopharmaceuticals Prices $6.0 Million Public Offering of Common Stock

Business Wire June 13, 2019

Navidea Biopharmaceuticals Announces Proposed Public Offering of Common Stock

Business Wire June 13, 2019

Navidea Biopharmaceuticals Regains Direct Control of Intellectual Property

Business Wire June 13, 2019

Navidea Biopharmaceuticals Reports First Quarter 2019 Financial Results

Business Wire May 8, 2019

Navidea Biopharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update

Business Wire May 1, 2019

Navidea Biopharmaceuticals Announces Comparative Study to Evaluate the Potential Utility of Tilmanocept In Patients with Tuberculosis ("TB")

Business Wire April 26, 2019

Navidea Biopharmaceuticals Announces Reverse Stock Split

Business Wire April 19, 2019

Mid-Day Market Update: Crude Oil Up 1.7%; BP Prudhoe Bay Royalty Trust Shares Plunge

Benzinga.com  April 8, 2019

Navidea Biopharmaceuticals Receives FDA Feedback Regarding Rheumatoid Arthritis Clinical Trial Design and Provides Business Updates

Business Wire April 8, 2019

Navidea Biopharmaceuticals Data to be Presented at Society of Nuclear Medicine and Molecular Imaging Annual Meeting

Business Wire April 2, 2019

Navidea Biopharmaceuticals Announces Stock Purchase Agreement; Other Business Updates

Business Wire March 22, 2019